Key Highlights

  • Edgewell Personal Care (NYSE:EPC) reported Q3 fiscal 2026 adjusted EPS of $0.72, beating the $0.64 estimate by 12.5 percent.
  • Organic net sales grew 1.1 percent, with North America organic sales up 3 percent.
  • Adjusted gross margin expanded 30 basis points to $79.8 million despite unfavorable currency impacts.
  • The company narrowed full-year fiscal 2026 guidance and expects fiscal 2027 guidance at the November year-end earnings call.

An EPS Beat Amid Mixed Regional Sales Performance

Edgewell Personal Care (NYSE:EPC), a global manufacturer and marketer of personal care products headquartered in Shelton, Connecticut, with operations in approximately 20 countries and available in more than 50 markets, reported third quarter fiscal 2026 organic net sales growth of 1.1 percent, with North America organic sales up 3 percent driven by double-digit grooming growth, mid-single digit sun and skin growth, and a return to weaker sun and skin growth. International organic sales declined 14 percent due to Middle East conflict impacts, private label supply disruptions, and a weaker Europe/Latam sun season start, though international growth is expected to reaccelerate in Q4.

Adjusted EPS was $0.72, flat year-over-year, exceeding the $0.64 estimate by 12.5 percent, while adjusted EBITDA was $78.9 million versus $81.2 million prior year, and adjusted gross margin declined 30 basis points, though gross margin expansion of approximately 40 basis points was favorable currency offset by unfavorable mix and inflation impacts. Revenue of $576 million missed the $570.1 million estimate by 1.02 percent, a modest shortfall relative to the more substantial EPS outperformance.

Guidance Narrowed as Company Cites Regional Growth Momentum

Full year fiscal 2026 guidance was narrowed, with organic net sales now expected flat to up 50 basis points from prior guidance of 0.04 percent favorable FX impact, adjusted EBITDA expected between $245 to $260 million, and adjusted gross margin expansion of 30 to 40 basis points, favorable currency offset by unfavorable inflation and mix impacts, and material input cost expansion expected in Q4 driven by productivity savings, cycling of one-time costs, and favorable FX.

Company highlighted strength in key brands including Cremo, seventh consecutive quarter of approximately 20 percent-plus growth, Hawaiian Tropic, now number 4 brand in Suncare, up number 5, with 110 basis share improvement, and Billie, continued sharing gains and household penetration growth, driven primarily by private label. Management expressed confidence in entering fiscal 2027 from a position of strength based on four factors: improved executive capabilities, a more focused portfolio post-Fem Care divestiture, improving M&A performance, and an accelerating operational transformation, including AI and analytics investment; company declined to comment on rumors regarding an unsolicited acquisition offer but stated the board follows fiduciary duty processes for any inbound proposals, with full fiscal 2027 guidance to be provided at the November year-end earnings call.

Balancing International Headwinds Against a Reaccelerating Domestic Business

Edgewell's near-term outlook will likely depend on whether the anticipated fourth quarter reacceleration in international organic sales materializes as management expects, particularly given that the 14 percent international decline was attributed largely to external factors including the Middle East conflict and private label supply disruptions rather than a broader demand deterioration. Should these disruptions ease as anticipated, international performance could improve meaningfully in the coming quarter.

On the domestic side, continued strength in brands like Cremo, Hawaiian Tropic, and Billie provides a supportive foundation for North America organic sales growth, which posted a solid 3 percent gain during the quarter. The company's stated confidence entering fiscal 2027, supported by a more focused portfolio following the Fem Care divestiture and accelerating operational transformation initiatives, suggests management sees a path toward improved performance even as it declined to comment on reported acquisition interest.

Conclusion

Edgewell Personal Care's third quarter results reflect a business navigating a sharp divergence between solid North America growth and significant international headwinds tied to geopolitical and supply chain disruptions, resulting in a narrowed full-year guidance range. Whether the anticipated fourth quarter international reacceleration materializes may shape how the company enters fiscal 2027, a year management has expressed confidence in given a more focused portfolio and accelerating operational transformation. Continued brand strength in categories like grooming and sun care provides a foundation for growth even amid the current mixed regional performance.